HAVCR2 and colorectal cancer: Similar findings were reported in colorectal cancer, where TIM-3+PD-1+CD8+ TILs represented the predominant fraction of TILs and targeting both TIM-3 and PD-1 enhanced cell expansion, cytokine production, and cytotoxic activity (166).